🇺🇸 FDA
Patent

US 7604944

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

granted A61PA61P35/00A61P43/00

Quick answer

US patent 7604944 (Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same) held by Theravance, Inc. expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00, A61P43/00